Follicular Carcinoma of the Thyroid Gland: Prognostic Factors, Treatment, and Survival
Comparison of Preoperative Embolization Followed by Radical Nephrectomy with Radical Nephrectomy Alone for Renal Cell Carcinoma
A Phase II Trial of Tamoxifen, Ifosfamide, Epirubicin, and Cisplatin Combination Chemotherapy for Inoperable Non–Small-Cell Lung Cancer
Late Pulmonary Effects in Favorable Stage I and IIA Hodgkin’s Disease Treated With Radiotherapy Alone
Ambamustine in the Second-Line Treatment of Patients With Small-Cell Lung Cancer
Kaposi Sarcoma After Treatment of Hodgkin’s Disease in a Young Adult Non-AIDS Patient
‘Full Dose’ Reirradiation of Human Cervical Spinal Cord
Thoracic Wall Prosthesis Prevents Deep Invasion by Non–Small-Cell Lung Cancer
Sustained Ventricular Tachycardia and Its Successful Prophylaxis During High-Dose Bolus Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma
A Phase II Trial of 5-Fluorouracil, Leucovorin, and Interferon Alpha 2A (IFN-α 2a) in Metastatic Pancreatic Carcinoma
Continuous-Infusion High-Dose Leucovorin With 5-Fluorouracil and Cisplatin for Relapsed Metastatic Breast Cancer: A Phase II Study
Pyomyositis After Chemotherapy for Breast Cancer
Treatment of Squamous Cell Esophageal Cancer With Topotecan
Accuracy and Clinical Impact of Mediastinal Lymph Node Staging with FDG–PET Imaging in Potentially Resectable Lung Cancer
The Roles of Chemotherapy and Surgery in Gastric Carcinoma and the Influence of Prognostic Factors on Survival
Poorly Differentiated Carcinoma of the Lung Presenting With Lambert—Eaton Myasthenic Syndrome
A Phase II Trial of Vinorelbine and Cisplatin in Previously Untreated Inoperable Non—Small-Cell Lung Cancer
Oral Etoposide for Merkel Cell Carcinoma in Patients Previously Treated With Intravenous Etoposide
Phase II Study of Doxorubicin and Paclitaxel as Second-Line Chemotherapy of Small-Cell Lung Cancer
Warfarin Is Safe as Secondary Prophylaxis in Patients With Cancer and a Previous Episode of Venous Thrombosis
Thrombotic Thrombocytopenic Purpura in Metastatic Carcinoma of the Breast
A Phase I Trial of Gemcitabine and Infusional 5-Fluorouracil (5-FU) in Patients with Refractory Solid Tumors
Preliminary Results of the Use of Re-186-HEDP for Palliation of Pain in Patients With Metastatic Bone Disease
Short-Course Palliative Radiotherapy in Non–Small-Cell Lung Cancer
Standard Dose (Mayo Regimen) 5-Fluorouracil and Low Dose Folinic Acid: Prohibitive Toxicity?
Synchronous Primary Cancers of the Breast and Cervix: Planning Multidisciplinary Primary Treatment
Correlation Between Water Proton Spin Lattice Relaxation Time and Radiation Tolerance Dose in Normal Human Tissue